Fever News and Research

RSS

Omicron BA.2 causes more symptoms and a greater disruption to daily life

In a recent study published in the Nature Communications journal, researchers monitored the changing symptom profiles associated with different severe acute respiratory syndrome CoV-2 (SARS-CoV-2) variants, especially Omicron subvariants BA.1 and BA.2.

16 Nov 2022

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades.

16 Nov 2022

SARS-CoV-2 infection triggers reactivation of latent viruses in people with chronic fatigue syndrome

COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.

16 Nov 2022

Study highlights link between the induction of fever and antibody levels after COVID-19 mRNA vaccine

mRNA vaccines for COVID-19 generate adverse reactions such as fever and fatigue which are considered normal and are transient in nature.

15 Nov 2022

Do SSRIs lower the risk of long COVID?

Researchers conducted a retrospective study to determine whether SSRIs with immunomodulatory and antiplatelet properties can decrease the risk of post-acute sequelae of COVID-19 (PASC).

15 Nov 2022

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Researchers examined the prevalence of changes in liver enzymes in COVID-19.

15 Nov 2022

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

Researchers investigated coronavirus disease 2019 (COVID-19)-associated morbidity in children, adolescents, and adults using healthcare data covering ~46% of the German population.

14 Nov 2022

More adverse reactions following bivalent COVID-19 mRNA booster vaccine

A recent study posted to medRxiv* examined adverse reactions after administration of a bivalent BNT162b2 coronavirus disease 2019 (COVID-19) vaccine booster.

13 Nov 2022

Can monkeypox infection lead to myocarditis?

A recent study presents the first known case of myocarditis as a complication of monkeypox virus infection.

13 Nov 2022

Surge in RSV cases – how worried should you be?

RSV hospitalizations are reaching similarly high levels much earlier than normal this year.

10 Nov 2022

People of all age groups are at risk of post-COVID-19 syndrome, study says

Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom complexes, according to a new study publishing November 10th in the open access journal PLOS Medicine by Martin Roessler of Technische Universität Dresden, Germany, and colleagues.

10 Nov 2022

Melatonin could be a potential therapy for long-COVID symptoms

A recent review published in the journal Biomolecules discussed the potential uses of melatonin in treating brain fog, and chronic fatigue syndrome or myalgic encephalomyelitis symptoms associated with long coronavirus disease (COVID)

9 Nov 2022

Pioneering research identifies a promising treatment approach for myelofibrosis

Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

9 Nov 2022

What are the eye complications associated with monkeypox infection?

A new study describes the association between monkeypox infection and eye complications in humans.

9 Nov 2022

Can prostaglandin E2 injection improve hair growth?

A new study demonstrated that prostaglandin E2 (PGE2) stimulates hair follicle growth.

9 Nov 2022

Mortality rate and risk among hospitalized COVID-19 patients during different surges of the pandemic

Researchers assessed the mortality rates associated with SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) variant infections.

9 Nov 2022

Evaluating dual direct-acting antivirals against persistent COVID-19

Researchers assessed the efficiency of dual direct-acting antivirals in treating persistent coronavirus disease 2019 (COVID-19).

7 Nov 2022

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found.

4 Nov 2022

What is the correlation between specific COVID-19 clinical characteristics and anti-SARS-CoV-2 antibody titers?

Researchers investigated the associations between clinical characteristics of coronavirus disease 2019 (COVID-19) and immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

3 Nov 2022

RSV and kids: What you need to know

An overview on the prevalence, symptoms, and management of RSV in children.

2 Nov 2022

Fever News and Research

Omicron BA.2 causes more symptoms and a greater disruption to daily life

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

SARS-CoV-2 infection triggers reactivation of latent viruses in people with chronic fatigue syndrome

Study highlights link between the induction of fever and antibody levels after COVID-19 mRNA vaccine

Do SSRIs lower the risk of long COVID?

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

More adverse reactions following bivalent COVID-19 mRNA booster vaccine

Can monkeypox infection lead to myocarditis?

Surge in RSV cases – how worried should you be?

People of all age groups are at risk of post-COVID-19 syndrome, study says

Melatonin could be a potential therapy for long-COVID symptoms

Pioneering research identifies a promising treatment approach for myelofibrosis

What are the eye complications associated with monkeypox infection?

Can prostaglandin E2 injection improve hair growth?

Mortality rate and risk among hospitalized COVID-19 patients during different surges of the pandemic

Evaluating dual direct-acting antivirals against persistent COVID-19

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

What is the correlation between specific COVID-19 clinical characteristics and anti-SARS-CoV-2 antibody titers?

RSV and kids: What you need to know

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News